United States · Series G startup
2 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$54Mraised across 2 rounds since 2001, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding record
No investor was named in the report.
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
Immunicon (Now VERIDEX a Johnson & Johnson Co.)'s investors include Canaan, Johnson & Johnson Development Corporation (JJDC), Burrill & Company, TL Ventures and Wheatley Partners.
Immunicon (Now VERIDEX a Johnson & Johnson Co.) has raised $54M across 2 rounds since 2001.
Immunicon (Now VERIDEX a Johnson & Johnson Co.)'s most recent round was a Series G of $25M in Jul 2003.
Immunicon (Now VERIDEX a Johnson & Johnson Co.)'s largest round on record is $29M (Series F), in Jun 2001.
Immunicon (Now VERIDEX a Johnson & Johnson Co.)'s first round on record, in Jul 2003, was backed by Canaan, Johnson & Johnson Development Corporation (JJDC) and Burrill & Company and 2 others.
Immunicon (Now VERIDEX a Johnson & Johnson Co.)'s latest named round is a Series G, in Jul 2003.
Immunicon (Now VERIDEX a Johnson & Johnson Co.) is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
